Hennion & Walsh Asset Management, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 85,871 shares of HRMY stock, worth $2.54 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
85,871
Previous 75,072
14.38%
Holding current value
$2.54 Million
Previous $2.58 Million
10.34%
% of portfolio
0.13%
Previous 0.12%
Shares
14 transactions
Others Institutions Holding HRMY
# of Institutions
261Shares Held
46.9MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$195 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$172 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$67.3 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$46.7 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.75B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...